NCRI 2019 | Targeted screening and risk stratification of prostate cancer – updates from the IMPACT study

Rosalind Eeles

Rosalind Eeles, MD, PhD, The Institute of Cancer Research, London, UK, gives an update on the IMPACT study aiming to target screening in men at higher genetic risk of prostate cancer. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

Share this video